David P. Southwell, Director at PTC THERAPEUTICS, INC. (PTCT), sold 23,604 shares at $47.50 ($1.1M) on 2015-07-06, disclosed to the SEC on 2015-07-06.
Scheduled sale ($1.1M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $47.50 | 22,904 | $1.1M | 97.0% |
| 2 | $48.22 | 700 | $34K | 3.0% |
| Total | $47.52 avg | 23,604 | $1.1M | 100% |
| Filing → |
| PTCT | SELL | 2023-04-19 | $1.2M | — | Filing → |
| PTCT | SELL | 2023-04-04 | $257K | — | Filing → |
| PTCT | SELL | 2023-03-29 | $897K | — | Filing → |